scispace - formally typeset
D

Denise S. Fernandez-Twinn

Researcher at University of Cambridge

Publications -  63
Citations -  3604

Denise S. Fernandez-Twinn is an academic researcher from University of Cambridge. The author has contributed to research in topics: Offspring & Pregnancy. The author has an hindex of 30, co-authored 55 publications receiving 2958 citations. Previous affiliations of Denise S. Fernandez-Twinn include Wellcome Trust & Medical Research Council.

Papers
More filters
Journal ArticleDOI

Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice

TL;DR: Maternal obesity programs development of a dysmetabolic and NAFLD phenotype, which is critically dependent on the early postnatal period and possibly involving alteration of hypothalamic appetite nuclei signalling by maternal breast milk and neonatal adipose tissue derived, leptin, is studied.
Journal ArticleDOI

Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome.

TL;DR: This work has utilised various species to test the early life programming hypothesis and to identify key molecular mechanisms which can be validated as realistic targets for intervention.
Journal ArticleDOI

Maternal protein restriction leads to hyperinsulinemia and reduced insulin-signaling protein expression in 21-mo-old female rat offspring.

TL;DR: Observations suggest that intrauterine protein restriction leads to insulin resistance in females in old age and, hence, an increased risk of type 2 diabetes.
Journal ArticleDOI

Early life nutrition and metabolic programming

TL;DR: The epidemiological evidence for programming of metabolic disease is explored and an overview of the various studies using animals to model metabolic phenotypic outcome is provided to discuss evidence for the proposed molecular mechanisms and the potential for intervention.
Journal ArticleDOI

Fetal growth and adult diseases

TL;DR: This short review focuses on fetal programming of appetite and obesity, coronary artery disease and hypertension, type-2 diabetes, and cancer.